Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Sep 03, 2021 9:10am
204 Views
Post# 33808507

RE:RE:$omething is VERY wrong here.....

RE:RE:$omething is VERY wrong here.....Yes, TLTs ACT will be pricy at first, but given how expensive NMIBC is to treat it will only be about half what an insurance company will pay out, so TLT should have the insurance lobbyists on their side. And TLTs ACT will include a CLT Pretreatment, Vaccine, Instilations/Dosimetry, X-ray or Laser. Two treatments as standard. All of which TLT can bill for. The patient will only have to deal with this two days per year, hopefully only that first year, a few hours each time. :-)

Lamusica wrote: My opinion is that curing a disease is not as important as treating a disease.  TLT has some great success in eliminating cancer.  Which means that the patient will not make as much money for a pharmaceutical company as a long lasting treatment... unless the price of the 1 treatment from TLT technology is priced the same as an on going long term treatment.  



<< Previous
Bullboard Posts
Next >>